Key Points- U.S. patients and drugmakers will get a first glimpse of how much Medicare can negotiate down drug prices in 2024.- Next year could set the precedent for a controversial process that may affect the prices seniors pay for dozens of medications by the end of the decade. – It could also be a […]
